Apollo Commercial Real Estate Finance (ARI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
9 Mar, 2026Executive summary
A special meeting is called to approve the sale of the commercial real estate loan portfolio to Athene Holding Ltd., the issuance of common stock to the manager in lieu of cash, and potential adjournment to solicit more votes if needed.
The asset sale involves selling nearly all commercial real estate loans, excluding two expected to be repaid before closing, for 99.7% of the total commitment amount, paid in cash.
The board, following a unanimous special committee recommendation, urges shareholders to vote in favor of all proposals, citing strategic flexibility and value maximization.
The transaction is expected to yield $1.4 billion in net cash and $1.7 billion in equity, with proceeds to be used for new strategies or potential dissolution if no new direction is set by year-end.
Voting matters and shareholder proposals
Shareholders will vote on: (1) the asset sale to Athene, (2) issuance of common stock to the manager, and (3) adjournment of the meeting if more votes are needed.
Approval of the asset sale requires a majority of all votes entitled to be cast; the stock issuance and adjournment proposals require a majority of votes cast.
Failure to vote or abstentions count as votes against the asset sale but not against the other proposals.
No appraisal rights are granted to shareholders for this transaction.
Board of directors and corporate governance
The special committee, composed of independent directors, led the negotiation and evaluation process, engaging legal and financial advisors.
Two directors with ties to Apollo recused themselves from voting on the asset sale and management agreement.
The board recommends voting for all proposals, citing the fairness opinion and strategic rationale.
Latest events from Apollo Commercial Real Estate Finance
- $8.8B loan portfolio, 9.4% yield, and robust Apollo backing drive strong performance.ARI
Investor presentation9 Mar 2026 - Shareholders are asked to approve a $9B commercial loan sale to Athene, offering higher yields.ARI
Proxy Filing20 Feb 2026 - Portfolio sale prompts asset value maximization and strategic review, with shareholder vote pending.ARI
Proxy Filing12 Feb 2026 - 2025 net income was $114M; full loan portfolio sale to Athene at 99.7% of commitments.ARI
Q4 202511 Feb 2026 - Stockholders to vote on $9B asset transfer to Athene, aiming to enhance value and efficiency.ARI
Proxy Filing10 Feb 2026 - Proposed $9B real estate loan portfolio acquisition highlights disciplined, long-term strategy.ARI
Proxy Filing6 Feb 2026 - $9B real estate loan portfolio acquired with robust oversight and long-term investment focus.ARI
Proxy Filing6 Feb 2026 - $9B loan portfolio sale at 99.7% unlocks $1.4B cash, validates book, and enables strategic review.ARI
Status update3 Feb 2026 - Q2 distributable earnings $0.35/share; $90M CECL reserve expected for healthcare loan.ARI
Q2 20242 Feb 2026